Skip to main content

Test Price

4,000 AED

✅ Home Collection Available

Chromofic KaryoArray™ Test in UAE | 4000 AED | DHA Licensed Genetic Analysis

Executive Summary & Core Metrics

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing (Cert: INT/EGQ/2509DA/3139).
  • Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection across all Emirates (daily 8 AM – 11 PM).
  • Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance for result interpretation by a DHA-licensed Consultant Medical Geneticist.
  • Insurance: Instant Direct Billing Verification via WhatsApp at +971 54 548 8731.

Test Overview & Methodology

The Chromofic KaryoArray™ Test is a high-resolution chromosomal microarray (CMA) specifically designed to uncover submicroscopic copy‑number variations (CNVs) and loss of heterozygosity in disorders of the nervous system. This DHA‑aligned assay integrates Affymetrix CytoScan™ 750K SNP‑microarray technology with confirmatory light microscopy, delivering a clinically actionable genomic map within 10 working days. The test is processed at DNA Labs UAE under ISO 9001:2015 certification, ensuring stringent quality control and traceability throughout the analytical pipeline.

Feature Chromofic KaryoArray™ (Our Test) Closest Alternative (Conventional Karyotype)
Precision ~25 kb resolution (750K SNP probes + microscopy) 5–10 Mb band resolution
Methodology Affymetrix CytoScan™ 750K Microarray + Confirmatory Light Microscopy G‑banded karyotyping only
Turnaround Time 10 working days 14–21 days
Clinical Scope CNVs, UPD, LOH, mosaicism — neurodevelopmental & congenital anomalies Aneuploidies & large structural rearrangements only

Physician Insight & Safety Protocols

“Chromofic KaryoArray™ delivers a genomic resolution unattainable by conventional karyotyping, enabling the detection of submicroscopic CNVs and LOH regions critical for neurodevelopmental diagnoses. Every result is interpreted within the full clinical context and correlated with the patient’s developmental history by our multidisciplinary team. This test is a powerful complement to—not a substitute for—ongoing clinical assessment.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403.

Advisory Notice

Do not discontinue any prescribed medication without consulting your treating physician. This test does not replace ongoing neurological management or emergency care protocols.

Exclusion Criteria & Emergency Red Flags

  • Not indicated for acute infections, metabolic crises, or emergency diagnostics.
  • If the patient experiences new‑onset seizures, loss of consciousness, or sudden severe developmental regression, seek immediate emergency care.
  • Home collection is contraindicated in hemodynamically unstable patients; hospital‑based phlebotomy will be arranged.
  • Ensure the mandatory Genomic Microarray Requisition Form (Form 19) is fully completed prior to sample collection.

Patient FAQ & Clinical Guidance

1. What is the Chromofic KaryoArray™ Test and how does it differ from a standard karyotype?

This test detects submicroscopic chromosomal imbalances such as deletions, duplications, and regions of homozygosity that remain invisible under a standard microscope. By combining SNP‑microarray analysis with confirmatory light microscopy, it dramatically improves diagnostic yield for unexplained neurodevelopmental disorders, offering ~25 kb resolution versus the 5–10 Mb resolution of conventional G‑banded karyotyping.

2. What sample types are required and how should I prepare?

A total of 4 mL of whole blood is collected into two tubes: one EDTA (lavender) and one sodium heparin (green) tube. This dual collection preserves DNA integrity for the microarray and enables parallel cytogenetic microscopy. No special preparation is required, but please keep the patient well‑hydrated and inform the phlebotomist of any bleeding disorders or anticoagulant use.

3. Will I receive post‑test clinical guidance and interpretation support?

Yes, every Chromofic KaryoArray™ report includes a scheduled telephonic consultation with a DHA‑licensed Consultant Medical Geneticist or genetic counsellor who will walk you through the findings, their clinical significance, and recommended next steps. This complimentary service ensures that every result is translated into actionable care.

4. How is my genetic data protected under UAE law?

Your genetic information is handled in strict compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Results are encrypted, access‑controlled, and never shared without explicit written consent.

UAE Regulatory & Data Privacy Adherence

Regulatory Compliance Framework

This service strictly adheres to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability. All processing is performed under ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) at DHA Facility License No. 1143. DHA/MOHAP standard nomenclature is applied throughout.

For direct billing verification or to schedule home collection (available 8 AM – 11 PM daily), WhatsApp +971 54 548 8731.

Clinical & Logistical Metadata

Test Name Chromofic KaryoArray™ Test
Price (AED) 4,000 AED
Turnaround Time 10 Working Days
Sample Type / Matrix Whole Blood (EDTA & Sodium Heparin)
Methodology Used Affymetrix CytoScan™ 750K SNP Microarray + Confirmatory Light Microscopy
ICD-10-CM Code F88 (Neurodevelopmental disorder)
LOINC Code 81273-3
DHA Facility License & Address License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians